table of content
1 Study Coverage
1.1 Kidney Disease Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Kidney Disease Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Kidney Disease Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Kidney Disease Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Kidney Disease Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Kidney Disease Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Kidney Disease Drugs Sales by Region
2.4.1 Global Kidney Disease Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Kidney Disease Drugs by Region (2023-2028)
2.5 Global Kidney Disease Drugs Revenue by Region
2.5.1 Global Kidney Disease Drugs Revenue by Region (2017-2022)
2.5.2 Global Kidney Disease Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Kidney Disease Drugs Sales by Manufacturers
3.1.1 Global Top Kidney Disease Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Kidney Disease Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Kidney Disease Drugs in 2021
3.2 Global Kidney Disease Drugs Revenue by Manufacturers
3.2.1 Global Kidney Disease Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Kidney Disease Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Kidney Disease Drugs Revenue in 2021
3.3 Global Kidney Disease Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Kidney Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Kidney Disease Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Kidney Disease Drugs Sales by Type
4.1.1 Global Kidney Disease Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Kidney Disease Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Kidney Disease Drugs Sales Market Share by Type (2017-2028)
4.2 Global Kidney Disease Drugs Revenue by Type
4.2.1 Global Kidney Disease Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Kidney Disease Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Kidney Disease Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Kidney Disease Drugs Price by Type
4.3.1 Global Kidney Disease Drugs Price by Type (2017-2022)
4.3.2 Global Kidney Disease Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Kidney Disease Drugs Sales by Application
5.1.1 Global Kidney Disease Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Kidney Disease Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Kidney Disease Drugs Sales Market Share by Application (2017-2028)
5.2 Global Kidney Disease Drugs Revenue by Application
5.2.1 Global Kidney Disease Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Kidney Disease Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Kidney Disease Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Kidney Disease Drugs Price by Application
5.3.1 Global Kidney Disease Drugs Price by Application (2017-2022)
5.3.2 Global Kidney Disease Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Kidney Disease Drugs Market Size by Type
6.1.1 North America Kidney Disease Drugs Sales by Type (2017-2028)
6.1.2 North America Kidney Disease Drugs Revenue by Type (2017-2028)
6.2 North America Kidney Disease Drugs Market Size by Application
6.2.1 North America Kidney Disease Drugs Sales by Application (2017-2028)
6.2.2 North America Kidney Disease Drugs Revenue by Application (2017-2028)
6.3 North America Kidney Disease Drugs Market Size by Country
6.3.1 North America Kidney Disease Drugs Sales by Country (2017-2028)
6.3.2 North America Kidney Disease Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Kidney Disease Drugs Market Size by Type
7.1.1 Europe Kidney Disease Drugs Sales by Type (2017-2028)
7.1.2 Europe Kidney Disease Drugs Revenue by Type (2017-2028)
7.2 Europe Kidney Disease Drugs Market Size by Application
7.2.1 Europe Kidney Disease Drugs Sales by Application (2017-2028)
7.2.2 Europe Kidney Disease Drugs Revenue by Application (2017-2028)
7.3 Europe Kidney Disease Drugs Market Size by Country
7.3.1 Europe Kidney Disease Drugs Sales by Country (2017-2028)
7.3.2 Europe Kidney Disease Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Kidney Disease Drugs Market Size by Type
8.1.1 Asia Pacific Kidney Disease Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Kidney Disease Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Kidney Disease Drugs Market Size by Application
8.2.1 Asia Pacific Kidney Disease Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Kidney Disease Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Kidney Disease Drugs Market Size by Region
8.3.1 Asia Pacific Kidney Disease Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Kidney Disease Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Kidney Disease Drugs Market Size by Type
9.1.1 Latin America Kidney Disease Drugs Sales by Type (2017-2028)
9.1.2 Latin America Kidney Disease Drugs Revenue by Type (2017-2028)
9.2 Latin America Kidney Disease Drugs Market Size by Application
9.2.1 Latin America Kidney Disease Drugs Sales by Application (2017-2028)
9.2.2 Latin America Kidney Disease Drugs Revenue by Application (2017-2028)
9.3 Latin America Kidney Disease Drugs Market Size by Country
9.3.1 Latin America Kidney Disease Drugs Sales by Country (2017-2028)
9.3.2 Latin America Kidney Disease Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Kidney Disease Drugs Market Size by Type
10.1.1 Middle East and Africa Kidney Disease Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Kidney Disease Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Kidney Disease Drugs Market Size by Application
10.2.1 Middle East and Africa Kidney Disease Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Kidney Disease Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Kidney Disease Drugs Market Size by Country
10.3.1 Middle East and Africa Kidney Disease Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Kidney Disease Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Keryx Biopharmaceuticals
11.6.1 Keryx Biopharmaceuticals Corporation Information
11.6.2 Keryx Biopharmaceuticals Overview
11.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Keryx Biopharmaceuticals Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Keryx Biopharmaceuticals Recent Developments
11.7 Kissei Pharmaceutical
11.7.1 Kissei Pharmaceutical Corporation Information
11.7.2 Kissei Pharmaceutical Overview
11.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kissei Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kissei Pharmaceutical Recent Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Overview
11.8.3 AbbVie Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 AbbVie Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 AbbVie Recent Developments
11.9 Amgen
11.9.1 Amgen Corporation Information
11.9.2 Amgen Overview
11.9.3 Amgen Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amgen Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amgen Recent Developments
11.10 Teva Pharmaceutical Industries
11.10.1 Teva Pharmaceutical Industries Corporation Information
11.10.2 Teva Pharmaceutical Industries Overview
11.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Teva Pharmaceutical Industries Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Pharmaceutical Industries Recent Developments
11.11 Tianjin Tongrentang Group
11.11.1 Tianjin Tongrentang Group Corporation Information
11.11.2 Tianjin Tongrentang Group Overview
11.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Tianjin Tongrentang Group Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tianjin Tongrentang Group Recent Developments
11.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
11.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Corporation Information
11.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Overview
11.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Recent Developments
11.13 Datong Liqun Pharmaceutical
11.13.1 Datong Liqun Pharmaceutical Corporation Information
11.13.2 Datong Liqun Pharmaceutical Overview
11.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Datong Liqun Pharmaceutical Recent Developments
11.14 Hebei Ruisen Pharmaceutical
11.14.1 Hebei Ruisen Pharmaceutical Corporation Information
11.14.2 Hebei Ruisen Pharmaceutical Overview
11.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hebei Ruisen Pharmaceutical Recent Developments
11.15 Changxing Pharmaceutical
11.15.1 Changxing Pharmaceutical Corporation Information
11.15.2 Changxing Pharmaceutical Overview
11.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Changxing Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Changxing Pharmaceutical Recent Developments
11.16 zhejiang Shengbokang Pharmaceutical
11.16.1 zhejiang Shengbokang Pharmaceutical Corporation Information
11.16.2 zhejiang Shengbokang Pharmaceutical Overview
11.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 zhejiang Shengbokang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Kidney Disease Drugs Industry Chain Analysis
12.2 Kidney Disease Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Kidney Disease Drugs Production Mode & Process
12.4 Kidney Disease Drugs Sales and Marketing
12.4.1 Kidney Disease Drugs Sales Channels
12.4.2 Kidney Disease Drugs Distributors
12.5 Kidney Disease Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Kidney Disease Drugs Industry Trends
13.2 Kidney Disease Drugs Market Drivers
13.3 Kidney Disease Drugs Market Challenges
13.4 Kidney Disease Drugs Market Restraints
14 Key Findings in The Global Kidney Disease Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
